|
|
Volumn 179, Issue SUPPL. 3, 1999, Pages
|
|
Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis: Comments and conference summary
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CYTOKINE;
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
CONFERENCE PAPER;
CRYPTOSPORIDIUM;
CYTOTOXIC T LYMPHOCYTE;
EPIDEMIC;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION SENSITIVITY;
MACROPHAGE;
MICROSPORUM;
MUCOSAL IMMUNITY;
OPPORTUNISTIC INFECTION;
PATHOGENESIS;
PRIORITY JOURNAL;
SEXUALLY TRANSMITTED DISEASE;
SIMIAN IMMUNODEFICIENCY VIRUS;
SUPPRESSOR CELL;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
IMMUNITY, MUCOSAL;
MALE;
|
|
EID: 0032897499
PISSN: 00221899
EISSN: None
Source Type: Journal
DOI: 10.1086/314811 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (0)
|
